Skip to main content
. 2017 Sep 22;8(3):244–253. doi: 10.1177/2192568217722562

Table 3.

Patient Demographics, Hospital Characteristics, and Outcomes for PCF in the Treatment of CSMa.

2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 P
Number of PCFs 830 1017 989 1109 1182 1666 1454 1919 2228 2155 2416
Age* 61.8 62.2 62.4 61.6 62.6 62.4 63.0 62.7 63.8 63.5 63.3 <.01
Female* 306 (36.9) 426 (41.9) 407 (41.3) 453 (40.9) 480 (40.6) 676 (40.6) 542 (37.3) 812 (42.3) 855 (38.4) 891 (41.3) 1014 (42.0) <.01
Race
 White* 474 (57.1) 596 (58.6) 587 (59.4) 597 (53.8) 640 (54.1) 962 (57.7) 901 (62.0) 1256 (65.5) 1484 (66.6) 1507 (69.9) 1643 (68.0) <.01
 Black 111 (13.4) 111 (10.9) 93 (9.4) 142 (12.8) 117 (9.9) 204 (12.2) 168 (11.6) 284 (14.8) 370 (16.6) 315 (14.6) 392 (16.2) .17
 Other 62 (7.5) 58 (5.7) 71 (7.2) 90 (8.1) 127 (10.7) 136 (8.2) 172 (11.8) 172 (9.0) 265 (11.9) 232 (10.8) 237 (9.8) .16
Comorbidity
 0** 196 (23.6) 227 (22.3) 191 (19.3) 194 (17.5) 186 (15.7) 262 (15.7) 185 (12.7) 261 (13.6) 264 (11.8) 233 (10.8) 268 (11.1) <.001
 1** 267 (32.2) 307 (30.2) 250 (25.3) 274 (24.7) 286 (24.2) 383 (23.0) 355 (24.4) 433 (22.6) 480 (21.5) 479 (22.2) 488 (20.2) <.001
 2 201 (24.2) 242 (23.8) 262 (26.5) 270 (24.3) 308 (26.1) 413 (24.8) 352 (24.2) 427 (22.3) 513 (23.0) 467 (21.7) 587 (24.3) .86
 3+** 166 (20.0) 241 (23.7) 286 (28.9) 371 (33.5) 402 (34.0) 608 (36.5) 562 (38.7) 798 (41.6) 971 (43.6) 976 (45.3) 1073 (44.4) <.001
Insurance
 Private 298 (35.9) 373 (36.7) 384 (38.8) 434 (39.1) 426 (36.0) 579 (34.8) 514 (35.4) 652 (34.0) 741 (33.3) 686 (31.8) 793 (32.8) .15
 Medicare 417 (50.2) 503 (49.5) 476 (48.1) 545 (49.1) 583 (49.3) 825 (49.5) 715 (49.2) 965 (50.3) 1176 (52.8) 1167 (54.2) 1258 (52.1) .38
 Medicaid 55 (6.6) 66 (6.5) 71 (7.2) 70 (6.3) 82 (6.9) 133 (8.0) 106 (7.3) 135 (7.0) 154 (6.9) 147 (6.8) 190 (7.9) .32
 Uninsured 10 (1.2) 25 (2.5) 14 (1.4) 12 (1.1) 25 (2.1) 35 (2.1) 28 (1.9) 45 (2.3) 38 (1.7) 45 (2.1) 49 (2.0) .14
Academic hospital 605 (72.9) 778 (76.5) 609 (61.6) 832 (75.0) 851 (72.0) 1213 (72.8) 1010 (69.5) 1261 (65.7) 1612 (72.4) 1543 (71.6) 1767 (73.1) .92
Hospital size
 Small 53 (6.4) 79 (7.8) 79 (8.0) 134 (12.1) 145 (12.3) 64 (3.8) 113 (7.8) 197 (10.3) 189 (8.5) 186 (8.6) 217 (9.0) .17
 Medium 177 (21.3) 164 (16.1) 168 (17.0) 204 (18.4) 189 (16.0) 306 (18.4) 322 (22.1) 347 (18.1) 351 (15.8) 424 (19.7) 540 (22.4) .85
 Large 600 (72.3) 774 (76.1) 742 (75.0) 771 (69.5) 848 (71.7) 1296 (77.8) 1000 (68.8) 1352 (70.5) 1654 (74.2) 1545 (71.7) 1659 (68.7) .41
Hospital region
 Northeast 172 (20.7) 183 (18.0) 198 (20.0) 236 (21.3) 202 (17.1) 354 (21.2) 298 (20.5) 386 (20.1) 426 (19.1) 428 (19.9) 499 (20.7) .87
 Midwest 139 (16.7) 215 (21.1) 280 (28.3) 222 (20.0) 242 (20.5) 352 (21.1) 354 (24.3) 395 (20.6) 448 (20.1) 517 (24.0) 523 (21.6) .38
 South 428 (51.6) 460 (45.2) 356 (36.0) 460 (41.5) 506 (42.8) 677 (40.6) 492 (33.8) 707 (36.8) 829 (37.2) 726 (33.7) 873 (36.1) .06
 West 91 (11.0) 159 (15.6) 155 (15.7) 191 (17.2) 232 (19.6) 283 (17.0) 310 (21.3) 431 (22.5) 525 (23.6) 484 (22.5) 521 (21.6) .05
Mortality* 9 (1.1) 12 (1.2) 10 (1.0) 9 (0.8) 10 (0.8) 11 (0.7) 11 (0.8) 13 (0.7) 17 (0.8) 11 (0.5) 8 (0.3) <.01
LOS 6.1 6.5 6.3 6.4 6.2 5.9 6.4 6.5 6.5 6.0 5.8 .19
Hospital charge, $ (inflated to 2013)** 72 208 77 783 86 688 92 448 104 692 113 838 125 357 128 851 140 303 131 509 134 895 <.001

Abbreviations: PCF, posterior cervical fusion; CSM, cervical spondylotic myelopathy; LOS, length of stay; NIS, National Inpatient Sample.

aAll data is from the NIS and include patients over 18 years of age who underwent PCF in the treatment of CSM from 2003 to 2013. Data is expressed as a raw value with the percentage in parentheses. Data from 2003 was compared with 2013 for a single category to determine statistical significance.

*Denotes statistical significance at P < .01. **Denotes statistical significance at P < .001.